BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 28, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Melphalan delivered via Delcath's PHP system regulatory update

Delcath said FDA refused to file an NDA for melphalan delivered using the Delcath Percutaneous Hepatic Perfusion (PHP) System to treat melanoma metastatic to the liver. According to the company, the agency requested...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >